More on BAYRY
Data
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $10.40 |
|
|||
| Open | $10.36 | ||||
| 52 Wk High | $135.54 | ||||
| 52 Wk Low | $94.36 | ||||
| Day High | $10.39 | ||||
| Day Low | $10.30 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 140,870 | ||||
- Dr. Jost Reinhard Appointed President of Bayer’s Radiology Business
- Bayer names new consumer health division leaders to accelerate growth
- Bayer Announces Global Consumer Health Leadership Changes to Accelerate Growth
- Bayer's KERENDIA shows kidney benefits in non-diabetic patients
- Phase III FIND‑CKD Results Show Bayer’s KERENDIA® (finerenone) Improved eGFR Slope and Reduced Risk of a Composite Kidney-Cardiovascular Outcome in Adults with Non‑Diabetic Chronic Kidney Disea
- Bayer to Present First Full FIND-CKD Results Investigating KERENDIA® (finerenone) in Non-Diabetic Chronic Kidney Disease at ERA 2026
- Barclays on Bayer AG (BAYN:GR) (BAYRY): 'Conditional transfer of settlement to federal level adds noise'
- ASCO 2026: Bayer Shares New Findings for NUBEQA® (darolutamide) Regarding Cognitive Decline in Men with Advanced Prostate Cancer Compared to Enzalutamide in Phase II ARACOG Head-to-Head Trial
- UBS Reiterates Buy Rating on Bayer AG (BAYN:GR) (BAYRY)
- Morgan Stanley continues to see "material upside" in this big pharma stock
Entities mentioned with BAYRY
- Twitter | View Related Stories »
- FDA | View Related Stories »
- Definitive Agreement | View Related Stories »
- Earnings | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- Goldman Sachs | View Related Stories »
- Show More...
